Effect of Straub Rotarex system combined with drug-coated balloon in the treatment of femoral superficial artery stent stenosis and occlusive disease
Objective:To investigate the clinical efficacy of Straub Rotarex system combined with drug-coated balloon in the treatment of femoral superficial artery stent stenosis and occlusive disease.Methods:A total of 38 patients with superficial femoral artery in-stent restenosis occlusive disease admitted to our department from March 2021 to August 2022 were collected.They were divided into the control group(n=19)and observation group(n=19)according to different treatment methods.The observation group was treated with instrument rotation combined with drug-coated balloon dilation,while the control group was treated with thrombolysis and balloon dilation.All patients were treated with unilateral lesions.The ankle-brachial index(ABI),skin color and skin temperature,Rutherford grading,reconstruction rate and amputation rate of the two groups were compared before surgery,6 months and 12 months after surgery,and vascular occlusion was evaluated.Results:There was no significant differences in the clinical data between two groups before surgery(all P>0.05).At 6 months after surgery,the ABI of the observation group was 0.90±0.05 and the reconstruction rate was(95±2)%,while those of the control group was 0.70±0.15 and(73±3)%respectively.Compared with the control group,those of the observation group were significantly increased(both P<0.05).At 12 months after surgery,the ABI of the observation group was 0.85±0.20,the reconstruction rate was(82±3)%,and the amputation rate was(5±1)%,while those of the control group was 0.60±0.03,(63±6)%and(43±5)%respectively,with the statistically differences between groups(all P<0.05).At 6 months and 12 months after surgery,the Rutherford grade,skin color and skin temperature of the observation group were better than those of the control group(all P<0.05).Conclusion:Straub Rotarex system combined with drug-coated balloon angioplasty is safe and reliable in the treatment of superficial femoral artery in-stent restenosis and occlusion,and the therapeutic effect is better than that of thrombolysis combined with balloon angioplasty.